. 2006 Dec;176(6 Pt 2):S6-S10; quiz S3-5.
doi: 10.1016/j.juro.2006.09.016.
Recommendations for defining and treating high risk localized prostate cancer
Affiliations
- PMID: 17084170
- DOI: 10.1016/j.juro.2006.09.016
Item in Clipboard
Recommendations for defining and treating high risk localized prostate cancer
J Urol.
2006 Dec.
No abstract available
Similar articles
-
A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.J Urol. 2008 Aug;180(2):451-9; discussion 460. doi: 10.1016/j.juro.2008.04.004. Epub 2008 Jun 11. J Urol. 2008. PMID: 18550100 Review.
-
Advanced prostate cancer treatment guidelines: European perspective.BJU Int. 2004 Dec;94 Suppl 3:6. doi: 10.1111/j.1464-410X.2004.05136.x. BJU Int. 2004. PMID: 15521884 Review. No abstract available.
-
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.BJU Int. 2007 Jan;99 Suppl 1:13-6; discussion 17-8. doi: 10.1111/j.1464-410X.2007.06594.x. BJU Int. 2007. PMID: 17229162 Review.
-
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.J Urol. 2007 Feb;177(2):540-5. doi: 10.1016/j.juro.2006.10.097. J Urol. 2007. PMID: 17222629 Review.
-
Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.J Urol. 2007 Mar;177(3):911-5. doi: 10.1016/j.juro.2006.10.040. J Urol. 2007. PMID: 17296374
Cited by
-
The benefits and risks of testosterone replacement therapy: a review.Ther Clin Risk Manag. 2009 Jun;5(3):427-48. doi: 10.2147/tcrm.s3025. Epub 2009 Jun 22. Ther Clin Risk Manag. 2009. PMID: 19707253 Free PMC article.
-
Radical prostatectomy as primary treatment of high-risk prostate cancer.Curr Urol Rep. 2012 Apr;13(2):179-86. doi: 10.1007/s11934-012-0240-6. Curr Urol Rep. 2012. PMID: 22314881 Review.
-
Building Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer.JMIR Med Inform. 2015 Jul 10;3(3):e26. doi: 10.2196/medinform.4221. JMIR Med Inform. 2015. PMID: 26162314 Free PMC article.
-
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.Life (Basel). 2023 Apr 23;13(5):1072. doi: 10.3390/life13051072. Life (Basel). 2023. PMID: 37240717 Free PMC article.
-
Robotic radical prostatectomy in high-risk prostate cancer: current perspectives.Asian J Androl. 2015 Nov-Dec;17(6):908-15; discussion 913. doi: 10.4103/1008-682X.153541. Asian J Androl. 2015. PMID: 25994643 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
